VeriMomIst tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 in der Schwangerschaft sicher?
No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
Related ingredients
Frequently asked questions
- Ist tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 in der Schwangerschaft sicher?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
- Ist tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 während des Stillens sicher?
- No data indicating reproductive or lactation hazards, no regulatory classifications for breastfeeding risk. Topical cosmetic peptides are large molecules with low dermal penetration in available literature and no evidence of transfer into breast milk or lactation-specific adverse effects in human studies or regulatory assessments (sources: CosIng, PubChem, absence of SCCS/CIR concerns).
- Ist tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 sicher für Babyhaut?
- No evidence of developmental or infant‑specific reproductive toxicity. Peptides used in cosmetics are high molecular weight and generally show negligible dermal absorption; therefore exposure to infants (0–3 yr) from typical topical cosmetic use is expected to be minimal and no infant‑specific hazard is documented. No harmonised CLP flags or published infant toxicity data were found (sources: CosIng, PubChem, PubMed literature absence).
- Wie bewertet VeriMom tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1?
- VeriMom bewertet tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.